BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36867923)

  • 1. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
    Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
    Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
    Chun W; Tian J; Zhang Y
    Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
    Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
    Front Immunol; 2020; 11():233. PubMed ID: 32133007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
    Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
    Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new generation of mesenchymal stromal/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment.
    Hoseinzadeh A; Mahmoudi M; Rafatpanah H; Rezaieyazdi Z; Tavakol Afshari J; Hosseini S; Esmaeili SA
    Stem Cell Res Ther; 2023 Dec; 14(1):358. PubMed ID: 38072921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells can prevent or promote the progression of colon cancer based on their timing of administration.
    Hu W; Wang W; Jiang X; Wang Z; Lin R
    J Transl Med; 2023 Mar; 21(1):227. PubMed ID: 36978120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
    Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
    J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17
    Zhang M; Johnson-Stephenson TK; Wang W; Wang Y; Li J; Li L; Zen K; Chen X; Zhu D
    Stem Cell Res Ther; 2022 Sep; 13(1):484. PubMed ID: 36153633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
    Youd M; Blickarz C; Woodworth L; Touzjian T; Edling A; Tedstone J; Ruzek M; Tubo R; Kaplan J; Lodie T
    Clin Exp Immunol; 2010 Jul; 161(1):176-86. PubMed ID: 20456409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
    Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
    Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.